SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-000604 to XBP Global Holdings, Inc. (XBP)

XBP Global Holdings, Inc.
Date: Jan. 17, 2024 · CIK: 0001839530 · Accession: 0000000000-24-000604

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-276213

Date
January 17, 2024
Author
Not clearly detected
Form
UPLOAD
Company
XBP Global Holdings, Inc.

Letter

United States securities and exchange commission logo January 17, 2024 Andrej Jonovic Chief Executive Officer XBP Europe Holdings, Inc. 2701 East Grauwyler Road Irving, TX 75061 Re:XBP Europe Holdings, Inc. Registration Statement on Form S-1 Filed December 22, 2023 File No. 333-276213 Dear Andrej Jonovic: We have conducted a limited review of your registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Registration Statement on Form S-1 Cover Page 1.Revise your prospectus to disclose the price that each Selling Securityholder paid for the securities being registered for resale. Highlight any differences in the current trading price, the prices that the Sponsor, private placement investors or other Selling Securityholders acquired their shares and warrants, and the price that the public securityholders acquired their shares and warrants. Disclose that while the Sponsor, private placement investors or other Selling Securityholders may experience a positive rate of return based on the current trading price, the public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current trading price. Please also disclose the potential profit the Selling Securityholders will earn based on the current trading price. Lastly, please include appropriate risk factor disclosure, accordingly. We note the first two risk factors under the section titled "Risk Related to the Company" beginning on page 12.

FirstName LastNameAndrej Jonovic Comapany NameXBP Europe Holdings, Inc. January 17, 2024 Page 2 FirstName LastNameAndrej Jonovic XBP Europe Holdings, Inc. January 17, 2024 Page 2 2.Disclose the exercise prices of the Forward Purchase Warrants, Private Placement Warrants and Public Warrants, respectively, compared to the market price of the underlying securities. If any of each of these warrants are out the money, please disclose the likelihood that warrant holders will not exercise their warrants. Provide similar disclosure in the prospectus summary, risk factors, MD&A and use of proceeds section and disclose that cash proceeds associated with the exercises of the warrants are dependent on the stock price. As applicable, describe the impact on your liquidity and update the discussion on the ability of your company to fund your operations on a prospective basis with your current cash on hand. 3.We also note that a significant portion of the shares being registered for resale were purchased by the Selling Securityholders for prices considerably below the current market price of the Common Stock. Highlight here the significant negative impact sales of shares on this registration statement could have on the public trading price of the Common Stock. Additionally, we note that the shares being registered for resale will constitute a considerable percentage of your public float. Please revise your disclosure here, in your Risk Factors section and elsewhere as appropriate to disclose the amount of resale shares being registered as a percentage of your public float. We note your risk factor titled "Substantial future sales of shares of Common Stock could cause the market price of shares of Common Stock to decline" on page 12 as well as your risk factor beginning "The Company has a limited public float, which adversely affects trading volume a liquidity..." on page 28. 4.We note that certain shares being registered for resale were purchased by the Selling Securityholders for prices considerably below the current market price of the Common Stock. Expand your discussion in MD&A to highlight the significant negative impact sales of shares on this registration statement could have on the public trading price of the Common Stock. Your discussion should highlight the fact that Excela Technologies, Inc. and CFAC Holdings VIII, LLC, as beneficial holders of 72.3% and 22.9%, respectively, of your outstanding shares will be able to sell a significant amount of shares for so long as the registration statement of which this prospectus forms a part is available for use. We note your risk factor beginning "Substantial future sales of share of Common Stock could cause the market price of shares..." on page 12. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

FirstName LastNameAndrej Jonovic Comapany NameXBP Europe Holdings, Inc. January 17, 2024 Page 3 FirstName LastName Andrej Jonovic XBP Europe Holdings, Inc. January 17, 2024 Page 3 Please contact Kate Beukenkamp at 202-551-3861 or Donald Field at 202-551-3680 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Andrew Rodman

Show Raw Text
United States securities and exchange commission logo
January 17, 2024
Andrej Jonovic
Chief Executive Officer
XBP Europe Holdings, Inc.
2701 East Grauwyler Road
Irving, TX 75061
Re:XBP Europe Holdings, Inc.
Registration Statement on Form S-1
Filed December 22, 2023
File No. 333-276213
Dear Andrej Jonovic:
            We have conducted a limited review of your registration statement and have the
following comments.
            Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Registration Statement on Form S-1
Cover Page
1.Revise your prospectus to disclose the price that each Selling Securityholder paid for the
securities being registered for resale. Highlight any differences in the current trading
price, the prices that the Sponsor, private placement investors or other Selling
Securityholders acquired their shares and warrants, and the price that the public
securityholders acquired their shares and warrants. Disclose that while the Sponsor,
private placement investors or other Selling Securityholders may experience a positive
rate of return based on the current trading price, the public securityholders may not
experience a similar rate of return on the securities they purchased due to differences in
the purchase prices and the current trading price. Please also disclose the potential profit
the Selling Securityholders will earn based on the current trading price. Lastly, please
include appropriate risk factor disclosure, accordingly. We note the first two risk factors
under the section titled "Risk Related to the Company" beginning on page 12.

 FirstName LastNameAndrej  Jonovic
 Comapany NameXBP Europe Holdings, Inc.
 January 17, 2024 Page 2
 FirstName LastNameAndrej  Jonovic
XBP Europe Holdings, Inc.
January 17, 2024
Page 2
2.Disclose the exercise prices of the Forward Purchase Warrants, Private Placement
Warrants and Public Warrants, respectively, compared to the market price of the
underlying securities. If any of each of these warrants are out the money, please disclose
the likelihood that warrant holders will not exercise their warrants. Provide similar
disclosure in the prospectus summary, risk factors, MD&A and use of proceeds section
and disclose that cash proceeds associated with the exercises of the warrants are
dependent on the stock price. As applicable, describe the impact on your liquidity and
update the discussion on the ability of your company to fund your operations on a
prospective basis with your current cash on hand.
3.We also note that a significant portion of the shares being registered for resale were
purchased by the Selling Securityholders for prices considerably below the current market
price of the Common Stock. Highlight here the significant negative impact sales of shares
on this registration statement could have on the public trading price of the Common Stock.
Additionally, we note that the shares being registered for resale will constitute a
considerable percentage of your public float. Please revise your disclosure here, in your
Risk Factors section and elsewhere as appropriate to disclose the amount of resale shares
being registered as a percentage of your public float. We note your risk factor titled
"Substantial future sales of shares of Common Stock could cause the market price of
shares of Common Stock to decline" on page 12 as well as your risk factor beginning
"The Company has a limited public float, which adversely affects trading volume a
liquidity..." on page 28.
4.We note that certain shares being registered for resale were purchased by the Selling
Securityholders for prices considerably below the current market price of the Common
Stock. Expand your discussion in MD&A to highlight the significant negative impact
sales of shares on this registration statement could have on the public trading price of the
Common Stock. Your discussion should highlight the fact that Excela Technologies, Inc.
and CFAC Holdings VIII, LLC, as beneficial holders of 72.3% and 22.9%, respectively,
of your outstanding shares will be able to sell a significant amount of shares for so long as
the registration statement of which this prospectus forms a part is available for use. We
note your risk factor beginning "Substantial future sales of share of Common Stock could
cause the market price of shares..." on page 12.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.

 FirstName LastNameAndrej  Jonovic
 Comapany NameXBP Europe Holdings, Inc.
 January 17, 2024 Page 3
 FirstName LastName
Andrej  Jonovic
XBP Europe Holdings, Inc.
January 17, 2024
Page 3
             Please contact Kate Beukenkamp at 202-551-3861 or Donald Field at 202-551-3680 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       Andrew Rodman